Is 2024 the start of a brave new world in drug pricing?

Ben LinkJanuary 12, 2024WAC, AWP, PBM, Brand drugs, Generic drugs, NADAC, CVS, Express Scripts, Medicaid, Mark Cuban, Insulin, Flovent, Price increases, List prices, Rebates, American Rescue Plan, Inflation Reduction Act, AMP

Brand drug launch prices: A game of perspective

Ben LinkMarch 9, 2023Rebates, Launch, drug prices, Brand drugs, Inflation Reduction Act, Medicare, Lyrica, WAC, Adbry, Firazyr, Zolgensma, Trikafta, CPI, List prices

The Rise of the Drug Mix Empire

Ben LinkJanuary 2, 2021WAC, Brand drugs, List prices, Price increases, Medicaid, Launch

A new (free) tool to help track drug price changes

The start of each new year brings a lot of “new-ness,” including a new round of price increases on brand-name drugs. This year has been no exception, and the media has been all over the subject. Unfortunately, we’ve found it difficult to figure out the “so what?” behind all of these price increases. On one hand, we are being told that the pharmaceutical manufacturers are back to “business as usual,” while on the other we are being told that the number of price increases are down meaningfully from last year. Which one is it? This felt like an opportunity to inject a healthy dose of facts into this discussion. So we set out to build a dashboard, 46brooklyn’s Brand Drug Price Change Box Score, that lets you visualize all brand-name manufacturer list price changes that are publicly-reported each week, drill down to the manufacturer and drug level, strength level, and compare and contrast different periods.